| pubmed-article:12620289 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0021031 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0278250 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C1414301 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C1414377 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0059994 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
| pubmed-article:12620289 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
| pubmed-article:12620289 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12620289 | pubmed:dateCreated | 2003-3-6 | lld:pubmed |
| pubmed-article:12620289 | pubmed:abstractText | ETS proteins (such as PU.1, Fli-1 and ETS-1) have been shown to play important roles in normal and abnormal hematopoiesis. We examined the expression of the ELF subfamily of ETS genes (ELF-1, MEF and NERF) in acute myeloid leukemia (AML) cells using Northern blot analysis. ELF-1 and MEF were expressed in all samples, whereas NERF was not. The relative expression (RE) of MEF, but not ELF-1, was significantly lower (P<0.0001) in AML with t(8;21) and t(15;17) compared with AML with normal karyotype. The pattern of MEF expression was not uniform among cells with CD34(+)/CD33(+). It is suggested that the low RE of MEF might be part of a gene expression profile characterizing AML with a good prognosis. | lld:pubmed |
| pubmed-article:12620289 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12620289 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12620289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12620289 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12620289 | pubmed:month | May | lld:pubmed |
| pubmed-article:12620289 | pubmed:issn | 0145-2126 | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:TomonagaMasao... | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:TsutsumiChizu... | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:TsushimaHidek... | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:TaguchiJunJ | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:FukushimaTaku... | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:ScaddenDavidD | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:MiyazakiYasus... | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:YoshidaShinic... | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:KuriyamaKazut... | lld:pubmed |
| pubmed-article:12620289 | pubmed:author | pubmed-author:NimerStephenS | lld:pubmed |
| pubmed-article:12620289 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12620289 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:12620289 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12620289 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12620289 | pubmed:pagination | 387-92 | lld:pubmed |
| pubmed-article:12620289 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:meshHeading | pubmed-meshheading:12620289... | lld:pubmed |
| pubmed-article:12620289 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12620289 | pubmed:articleTitle | The level of MEF but not ELF-1 correlates with FAB subtype of acute myeloid leukemia and is low in good prognosis cases. | lld:pubmed |
| pubmed-article:12620289 | pubmed:affiliation | Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Nagasaki, Japan. | lld:pubmed |
| pubmed-article:12620289 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12620289 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12620289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12620289 | lld:pubmed |
